BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/17/2014 3:13:00 PM | Browse: 850 | Download: 1148
Publication Name World Journal of Gastroenterology
Manuscript ID 9666
Country South Korea
Received
2014-02-25 20:28
Peer-Review Started
2014-02-25 21:31
To Make the First Decision
2014-04-02 19:36
Return for Revision
2014-04-12 06:48
Revised
2014-05-25 07:54
Second Decision
2014-07-25 09:25
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-07-25 09:51
Articles in Press
2014-07-25 09:55
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-10-30 15:09
Publish the Manuscript Online
2014-11-17 15:12
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Case Report
Article Title Delayed hypersensitivity reaction resulting in maculopapular-type eruption due to entecavir in the treatment of chronic hepatitis B
Manuscript Source Unsolicited Manuscript
All Author List Jeong Tae Kim, Hye Won Jeong, Ki Hwa Choi, Tae Young Yoon, Nohyun Sung, Young Ki Choi, Eun Ha Kim and Hee Bok Chae
Funding Agency and Grant Number
Funding Agency Grant Number
Chungbuk National University Hospital (2013)
Corresponding Author Hee Bok Chae, MD, Department of Internal Medicine, College of Medicine and Medical Research Institute, Chungbuk National University, 52 Naesudong-ro, Heungdeok-gu, Cheongju 361-711, South Korea. hbhcae@chungbuk.ac.kr
Key Words Entecavir; Delayed type hypersensitivity; Maculopapular drug eruption; Dermatology; Adverse drug reaction; Chronic hepatitis B
Core Tip A potent efficacy and good overall safety profile has supported the rapid establishment of entecavir as a frequently prescribed antiviral nucleoside for treatment of chronic hepatitis B (CHB). Among the adverse drug reactions that have been reported in CHB patients, allergic dermatitis is especially rare, with only two cases in the literature to date. This report describes a pathologically and immunologically evidenced case of entecavir (ETV)-induced type Ⅳ delayed hypersensitivity reaction, which resolved upon ETV withdrawal.
Publish Date 2014-11-17 15:12
Citation Kim JT, Jeong HW, Choi KH, Yoon TY, Sung N, Choi YK, Kim EH, Chai HB. Delayed hypersensitivity reaction resulting in maculopapular-type eruption due to entecavir in the treatment of chronic hepatitis B. World J Gastroenterol 2014; 20(42): 15931-15936
URL http://www.wjgnet.com/1007-9327/full/v20/i42/15931.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i42.15931
Full Article (PDF) WJG-20-15931.pdf
Full Article (Word) WJG-20-15931.doc
Manuscript File 9666-Review.docx
Answering Reviewers 9666-Answering reviewers.pdf
Copyright License Agreement 9666-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 9666-Language certificate.pdf
Peer-review Report 9666-Peer review(s).pdf
Scientific Misconduct Check 9666-CrossCheck.jpg
Scientific Editor Work List 9666-Scientific editor work list.pdf